Figure 4 | Scientific Reports

Figure 4

From: Whole genome analysis identifies the association of TP53 genomic deletions with lower survival in Stage III colorectal cancer

Figure 4

Arm-level chr17p loss predicts for poorer survival in Stage III CRC. (A) Venn diagram for shared arm-level CNAs between the discovery and TCGA validation cohorts. (B) The Kaplan–Meier plots of the Stage III CRC discovery cohort as stratified by patients’ status of carrying the chr17p arm loss (SCNA_CHR_ARM_17p_del = 1 for yes, otherwise 0). Also shown are box plots for comparing (C) number of focal CNAs (D_N_Focals) and (D) number of arm-level CNAs (D_N_Arms) between patients carrying or not carrying the chr17p loss.

Back to article page